Clinical Trials
53 trialsIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
AG-120 in People With IDH1 Mutant Chondrosarcoma
Memorial Sloan Kettering Cancer Center
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Memorial Sloan Kettering Cancer Center
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Medical University of Graz
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Mayo Clinic
Proton Beam Therapy for Chondrosarcoma
M.D. Anderson Cancer Center
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
REGOSTA
Centre Leon Berard
ADER
Istituto Ortopedico Rizzoli
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
Quironsalud
CIRCLE
Istituto Ortopedico Rizzoli
Diagnostic and Therapeutic Targets in Cartilaginous Tumours
St. Anne's University Hospital Brno, Czech Republic
Proton Radiation for Chordomas and Chondrosarcomas
Abramson Cancer Center at Penn Medicine
Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
University of Iowa
REGOBONE
UNICANCER
PRIMHADRON
Hospices Civils de Lyon
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Medical College of Wisconsin
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
IRCCS Azienda Ospedaliero-Universitaria di Bologna
P1V2
Centre Antoine Lacassagne
ImmunoSarc
Grupo Espanol de Investigacion en Sarcomas
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Fred Hutchinson Cancer Center
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Osteosarcoma
Stanford University
CHIPT
Leiden University Medical Center
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
TANOs
Université de Reims Champagne-Ardenne
AIAC
Peking University People's Hospital
TQBSP
Peking University People's Hospital
Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma
Washington University School of Medicine
MACIST
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ADCVCTAST
N.N. Petrov National Medical Research Center of Oncology
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Wake Forest University Health Sciences
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
Peking University People's Hospital
CH01
University of Florida
CHONRAD
Centre Leon Berard
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Massachusetts General Hospital
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
CONDRO1
Istituto Ortopedico Rizzoli
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
University of Miami
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Rutgers, The State University of New Jersey
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
University of South Florida
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Memorial Sloan Kettering Cancer Center
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Sarcoma Alliance for Research through Collaboration